A strategy for giving intermittent, high doses of the anti-cancer drug sunitinib is well-tolerated by patients with advanced cancer and
Read more
tumors
Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors
Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation
Read more
Genetic testing cost effective for newly diagnosed gastrointestinal stromal tumors
Because gastrointestinal stromal tumors (GIST) are sensitive to the targeted small molecule therapy imatinib, oncologists tend to treat all patients
Read more
Scientists use two powerful immunotherapies to eradicate solid tumors
City of Hope scientists have combined two potent immunotherapies—an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy—to target
Read more
Study’ preliminary results show response of 32% in treatment of pancreatic tumors
Working with an international team of researchers, HonorHealth Research Institute and the Translational Genomics Research Institute (TGen), an affiliate of
Read more
New treatment approach uses killer cells to treat deadly brain tumors
Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading
Read more
Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumors
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen,
Read more
Schizophrenia drug combined with radiation shows promise in treating deadly brain tumors
Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to
Read more